386 related articles for article (PubMed ID: 18977273)
1. Estimation of acute oral toxicity using the No Observed Adverse Effect Level (NOAEL) from the 28 day repeated dose toxicity studies in rats.
Bulgheroni A; Kinsner-Ovaskainen A; Hoffmann S; Hartung T; Prieto P
Regul Toxicol Pharmacol; 2009 Feb; 53(1):16-9. PubMed ID: 18977273
[TBL] [Abstract][Full Text] [Related]
2. ECVAM's ongoing activities in the area of acute oral toxicity.
Kinsner-Ovaskainen A; Bulgheroni A; Hartung T; Prieto P
Toxicol In Vitro; 2009 Dec; 23(8):1535-40. PubMed ID: 19591916
[TBL] [Abstract][Full Text] [Related]
3. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
4. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
5. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
6. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
Box RJ; Spielmann H
Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
[TBL] [Abstract][Full Text] [Related]
7. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
[TBL] [Abstract][Full Text] [Related]
8. Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics.
Singh-Joy SD; McLain VC
Int J Toxicol; 2008; 27 Suppl 2():93-128. PubMed ID: 18830866
[TBL] [Abstract][Full Text] [Related]
9. Final report on the safety assessment of methoxyisopropanol and methoxyisopropyl acetate as used in cosmetics.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 2():25-39. PubMed ID: 18830862
[TBL] [Abstract][Full Text] [Related]
10. In vitro assessment of eye irritancy using the Reconstructed Human Corneal Epithelial SkinEthic HCE model: application to 435 substances from consumer products industry.
Cotovio J; Grandidier MH; Lelièvre D; Bremond C; Amsellem C; Maloug S; Ovigne JM; Loisel-Joubert S; Lee AV; Minondo AM; Capallere C; Bertino B; Alépée N; Tinois-Tessonneaud E; de Fraissinette Ade B; Meunier JR; Leclaire J
Toxicol In Vitro; 2010 Mar; 24(2):523-37. PubMed ID: 19913609
[TBL] [Abstract][Full Text] [Related]
11. Determination of genetic toxicity and potential carcinogenicity in vitro--challenges post the Seventh Amendment to the European Cosmetics Directive.
Tweats DJ; Scott AD; Westmoreland C; Carmichael PL
Mutagenesis; 2007 Jan; 22(1):5-13. PubMed ID: 17142828
[TBL] [Abstract][Full Text] [Related]
12. Oral acute toxic class method: a successful alternative to the oral LD50 test.
Schlede E; Genschow E; Spielmann H; Stropp G; Kayser D
Regul Toxicol Pharmacol; 2005 Jun; 42(1):15-23. PubMed ID: 15896439
[TBL] [Abstract][Full Text] [Related]
13. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
[TBL] [Abstract][Full Text] [Related]
14. Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility.
Dent MP
Regul Toxicol Pharmacol; 2007 Aug; 48(3):241-58. PubMed ID: 17512650
[TBL] [Abstract][Full Text] [Related]
15. Acute toxicity testing of chemicals-Opportunities to avoid redundant testing and use alternative approaches.
Creton S; Dewhurst IC; Earl LK; Gehen SC; Guest RL; Hotchkiss JA; Indans I; Woolhiser MR; Billington R
Crit Rev Toxicol; 2010 Jan; 40(1):50-83. PubMed ID: 20144136
[TBL] [Abstract][Full Text] [Related]
16. Dermal and inhalation acute toxic class methods: test procedures and biometric evaluations for the Globally Harmonized Classification System.
Holzhütter HG; Genschow E; Diener W; Schlede E
Arch Toxicol; 2003 May; 77(5):243-54. PubMed ID: 12734637
[TBL] [Abstract][Full Text] [Related]
17. The European ACuteTox project: a modern integrative in vitro approach to better prediction of acute toxicity.
Clemedson C
Clin Pharmacol Ther; 2008 Aug; 84(2):200-2. PubMed ID: 18679183
[TBL] [Abstract][Full Text] [Related]
18. Amended final report of the safety assessment of Drometrizole as used in cosmetics.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():63-75. PubMed ID: 18569163
[TBL] [Abstract][Full Text] [Related]
19. Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status.
Ukelis U; Kramer PJ; Olejniczak K; Mueller SO
Regul Toxicol Pharmacol; 2008 Jun; 51(1):108-18. PubMed ID: 18362045
[TBL] [Abstract][Full Text] [Related]
20. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
Lodén M; Ungerth L; Serup J
Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
